Last reviewed · How we verify
NCT05534607: NEAR
Natives Engaged in Alzheimers Research - 'Ike Kupuna
NA trial testing Ola Mau i ka Hula in Mild Cognitive Impairment in 192 participants. Currently enrolling.
15 June 2025
Quick facts
| Lead sponsor | University of Hawaii |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 192 |
| Start date | 15 September 2022 |
| Primary completion | 15 June 2025 |
| Estimated completion | 30 April 2027 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Ola Mau i ka Hula
Conditions studied
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
- Subjective Cognitive Impairment — all drugs for Subjective Cognitive Impairment →
Sponsor
University of Hawaii
Who can join
Adults 50 to 75, any sex, with Mild Cognitive Impairment or Subjective Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will conduct a group randomized trial to test the effects of a hula-based intervention in improving vascular risk factors for ADRD and cognitive complaints and function over 12 months.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The adaptation and evaluation of a culturally grounded lifestyle intervention to mitigate the risk of Alzheimer's disease and related dementias in Native Hawaiians and Pacific Islanders: A study protocol.
Kaholokula JK, Buchwald D, MacLehose R, Look M, et al · · 2025 · cited 1× · PMID 42147774 · DOI 10.1016/j.ssmmh.2025.100429
Verify or expand the search:
- PubMed search for NCT05534607
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mild Cognitive Impairment
Currently open trials in the same condition.
- NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
- NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting
Other University of Hawaii trials
Trials by the same sponsor.
- NCT06964633 — The Ku Ola Project: Enhancing Health Promotion Among Native Hawaiian Men. · NA · not yet recruiting
- NCT07038317 — A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status · NA · not yet recruiting
- NCT07075575 — Quit-Smoking Study for Native Hawaiians · NA · not yet recruiting
- NCT07075120 — Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer · Phase 1 · not yet recruiting
- NCT06978790 — Generative Artificial Intelligence Nurse Staffing Study · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05534607 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Hawaii
- Last refreshed: 1 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05534607.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing